HIV, immunodeficiencies and cancer: strengthening children’s immune defences
This research was completed on 6 September 2017
Published on 25 October 2014
Some children have weakened immune systems, making them vulnerable to infection and putting their lives at risk. This includes children with HIV, and children with severe immunodeficiencies and some blood cancers who need a stem cell transplant to restore their immune system. Although treatment helps strengthen the immune system, some children remain unusually susceptible to infection. Professor Robin Callard, of University College London’s Institute of Child Health, is investigating why. His findings could enable doctors to identify the best possible treatment for each individual child, so they have the highest possible chance of escaping infection and remaining healthy.
How are children’s lives affected now?
“Our immune system protects us from infection,” says Professor Callard. “Cells called T cells play a central role. Most of us have a huge repertoire of more than 10 million different T cells. This enables our immune system to recognise and destroy the many different viruses, bacteria and parasites that we might be exposed to throughout our lives,” says Professor Callard.
The diversity in our T cell population is important, because cells that recognise the chicken pox virus, for example, would not necessarily recognise the measles virus.
Unfortunately, some children have greatly reduced numbers of T cells, meaning they are more susceptible to infection. This includes children with HIV and children who have had stem cell transplants for some cancers or severe immunodeficiencies.
“Successful treatment can return T cell numbers to normal,” says Professor Callard. “However, it’s unclear what sort of treatment is best at restoring the diversity in the T cell population. Without that diversity, children remain vulnerable to infection.”
How could this research help?
Professor Callard aims to improve the long-term health of children with HIV, and children who are undergoing stem cell transplants, who have weakened immune systems.
“We are studying how children’s immune systems respond to treatment, using blood samples from around 1,000 children from the UK, Europe and Africa,” says Professor Callard. “We are assessing how the number of T cells increases with different approaches to treatment and whether the diversity in the T cell population is restored. Both factors are important.”
“Our findings could enable doctors to identify the best possible treatment for each individual child,” continues Professor Callard. “They may reveal, for example, how old children with HIV should be when starting antiviral treatment, the most appropriate drugs to use, and whether it helps to take a break from treatment. The ultimate goal is to optimise the long-term health of the immune system, giving children protection from infectious diseases throughout their lives.”
|Project Leader||Professor Robin E Callard PhD BA(maths) DSc|
|Location||Great Ormond Street Hospital for Children, London|
|Grant awarded||25 July 2014|
|Start date||7 September 2015|
|End date||6 September 2017|
We do not provide medical advice. If you would like more information about a condition or would like to talk to someone about your health, contact NHS Choices or speak to your GP. Please see our useful links page for some links to health information, organisations we are working with and other useful organisations. We hope you will find these useful. We are not responsible for the content of any of these sites.